|
|||||
      |
Data in the chart are compiled by PatentSight, a service of LexisNexis, that show the seven leading holders of machine learning and other A.I. patents by company in 2017 and 2021. . . . → Read More: Infographic – Chinese Companies Lead in A.I. Patents 
A new enterprise is formed to develop gene-editing therapies for mitochondrial disorders, rare inherited mutations in the energy centers of cells. . . . → Read More: Company Started for Gene Editing Rare Inherited Diseases 
A discoverer of therapeutic peptides signed licensing deals in the past few days with two drug makers that could bring the company as much as $3.3 billion. . . . → Read More: Peptide Discovery Company to Gain $3.3B in Licensing Deals  One comment - (Comments are closed)  Intellectual property, Joint ventures/collaborations, New products  Asia, biomedical, biotechnology, cancer, chemistry, Japan, licensing, life sciences, pharmaceuticals, physical sciences, university 
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal Comments are closed Intellectual property, Joint ventures/collaborations, New products biomedical, biotechnology, cancer, chemistry, licensing, life sciences, pharmaceuticals, physical sciences 
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe Comments are closed Intellectual property, New products, Regulations biomedical, economics, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals 
A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology. . . . → Read More: Patent Awarded for Focused Ultrasound Skin Treatments Comments are closed Intellectual property, New products biomedical, cancer, engineering, entrepreneurs, Europe, life sciences, medical device, patent, physical sciences, physics, USPTO 
A company making precision therapies for neurological disorders is acquiring rights to a compound first designed as a treatment for cancer, inflammation, and oxidative stress. . . . → Read More: Drug Licensed for Precision Autism Spectrum Therapies Comments are closed Intellectual property biomedical, biotechnology, chemistry, Europe, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences 
A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome 2 comments - (Comments are closed) Intellectual property biomedical, biotechnology, cancer, Europe, genomics, licensing, life sciences, patent, pharmaceuticals, university, USPTO 
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech. One comment - (Comments are closed) Intellectual property, New products biomedical, biotechnology, engineering, entrepreneurs, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, university 
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process. . . . → Read More: Cannabinoid Synthesis Process Licensed to Spin-Off Company Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, entrepreneurs, genomics, Israel, licensing, life sciences, pharmaceuticals, physical sciences, university |
||||
|
Copyright © 2023 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts